HIV infection increases the risk of acquiring Plasmodium vivax malaria: a 4-year cohort study in the Brazilian Amazon HIV and risk of vivax malaria

Abstract

Globally, malaria and human immunodeficiency virus (HIV) are both independently associated with a massive burden of disease and death. While their co-infection has been well studied for Plasmodium falciparum, scarce data exist regarding the association of P. vivax and HIV. In this cohort study, we assessed the effect of HIV on the risk of vivax malaria infection and recurrence during a 4-year follow-up period in an endemic area of the Brazilian Amazon. For the purpose of this study, we obtained clinical information from January 2012 to December 2016 from two databases. HIV screening data were acquired from the clinical information system at the tropical hospital Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD). The National Malaria Surveillance database (SIVEP malaria) was utilized to identify malaria infections during a 4-year follow-up period after diagnosis of HIV. Both datasets were combined via data linkage. Between 2012 and 2016, a total of 42,121 people were screened for HIV, with 1569 testing positive (3.7%). Out of all the patients diagnosed with HIV, 198 had at least one episode of P. vivax malaria in the follow-up. In the HIV-negative group, 711 participants had at least one P. vivax malaria episode. When comparing both groups, HIV patients had a 6.48 [(5.37–7.83); P < 0.0001] (adjusted relative risk) greater chance of acquiring P. vivax malaria. Moreover, being of the male gender [ARR = 1.41 (1.17–1.71); P < 0.0001], Amerindian ethnicity [ARR = 2.77 (1.46–5.28); P < 0.0001], and a resident in a municipality of the Metropolitan region of Manaus [ARR = 1.48 (1.02–2.15); P = 0.038] were independent risk factors associated with an increased risk of clinical malaria. Education ≥ 8 years [ARR = 0.41 (0.26–0.64); P < 0.0001] and living in the urban area [ARR = 0.44 (0.24–0.80); P = 0.007] were associated to a lower risk of P. vivax malaria. A total of 28 (14.1%) and 180 (25.3%) recurrences (at least a second clinical malaria episode) were reported in the HIV-positive and HIV-negative groups, respectively. After adjusting for sex and education, HIV-positive status was associated with a tendency towards protection from P. vivax malaria recurrences [ARR = 0.55 (0.27–1.10); P = 0.090]. HIV status was not associated with hospitalizations due to P. vivax malaria. CD4 + counts and viral load were not associated with recurrences of P. vivax malaria. No significant differences were found in the distribution of parasitemia between HIV-negative and HIV-positive P. vivax malaria patients. Our results suggest that HIV-positive status is a risk factor for vivax malaria infection, which represents an additional challenge that should be addressed during elimination efforts.

Curcumin‐loaded nanomedicines as therapeutic strategy in malaria management

“…Malaria is a complex disease to treat and manage because of the prevalence of drug‐resistant parasites (Greenwood et al, 2008). In addition, the co‐infection of malaria, HIV, and SARS‐CoV‐2 complicates the procedure of diagnosis and treatment (Guerra et al, 2022; Hussein et al, 2022). As a result, finding a new potential remedy to treat malaria is necessary, and antimalarial measures must be taken to prevent the spread of the disease.…”

HIV/malaria co-infection and its determinants among people living with HIV/AIDS in Yenagoa, Bayelsa state, Nigeria

“…HIV and malaria are two severe global public health issues (Gumel et al, 2021;Guerra et al, 2022). There is a significant geographic overlap between them globally, with the majority of those affected residing in sub-Saharan Africa, the Indian subcontinent, Southeast Asia, Latin America, and the Caribbean (Frischknecht & Fackler, 2016;Guerra et al, 2022). They result in more than two million yearly fatalities (Gumel et al, 2021).…”

“…Although research on co-infection with the most common form of malaria has been neglected in some regions of Nigeria, there has been significant evidence of a relationship between the increased risk of falciparum malaria among HIVinfected individuals during the past three decades (Guerra et al, 2022). To the best of our knowledge, there is a dearth of literature on HIV/Malaria co-infection among HIV-positive individuals and related determinants in Bayelsa State, Nigeria.…”

In silico Evaluation of the Inhibitory Potential of Cymbopogonol from Cymbopogon citratus Towards Falcipain-2 (FP2) Cysteine Protease of Plasmodium falciparum

“…1 In Sub-Saharan Africa, there is an increased rate of mortality and morbidity resulting from the prevalence of malaria. 2,47 Malaria which is an infectious disease has not only engendered deaths but has also resulted in economic hardship in Sub-Saharan Africa. 3,4,5 Malaria has been reported to affect a large population of children under 5 years of age, and this accounts for close to 70% of malaria deaths globally.…”